Literature DB >> 20017010

Effects of two variants of Roux-en-Y Gastric bypass on metabolism behaviour: focus on plasma ghrelin concentrations over a 2-year follow-up.

Noelia Pérez-Romero1, Assumpta Serra, Maria Luisa Granada, Miquel Rull, Antonio Alastrué, Maruja Navarro-Díaz, Ramón Romero, Jaime Fernández-Llamazares.   

Abstract

BACKGROUND: To study the effects of two variants of Roux-en-Y gastric bypass (RYGBP) on plasma ghrelin concentrations according to different exposure of gastric fundus to the nutrient pathway.
METHODS: A prospective longitudinal 2-year follow-up study was conducted. Ninety-six morbidly obese (MO) patients (age range: 41.6 +/- 9.6 years, body mass index: 53 +/- 9.5 kg/m(2)) were assigned to two bariatric surgical (BS) procedures: one that preserves food contact with gastric fundus (ringed RYGBP, n = 50) and the other that avoids it (modified RYGBP, n = 46). Different anthropometric and biochemical parameters were studied, focusing on ghrelin concentrations at baseline and 6, 12, and 24 months post-BS.
RESULTS: At 24 months post-BS, all metabolic parameters studied had improved in all patients compared with those at 1-year follow-up and baseline (p < 0.05). However, high-density lipoprotein cholesterol concentrations took 2 years to normalise in 80% of patients, interleukin-6 decreased significantly in relation to baseline only after 2 years from BS (p < 0.001), and tumour necrosis factor alpha concentrations did not significantly decrease during the 2 years of follow-up. Plasma ghrelin concentrations increased in both surgical groups compare to baseline during the first year (24.6% in modified RYGBP and 36.62% in ringed RYGBP) and remained stable at the second year of follow-up, with no statistical differences between groups.
CONCLUSIONS: In the second year of follow-up after BS, morbidity continued to improve in MO patients despite a lesser weight loss in relation to the first year. An increase in plasma ghrelin concentrations was found, regardless of nutrient contact with gastric fundus. Furthermore, changes in plasma ghrelin concentrations appeared to be independent of weight loss.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20017010     DOI: 10.1007/s11695-009-0035-0

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  57 in total

1.  The decrease in plasma ghrelin concentrations following bariatric surgery depends on the functional integrity of the fundus.

Authors:  Gema Frühbeck; Alberto Diez-Caballero; M Jesús Gil; Inés Montero; Javier Gómez-Ambrosi; Javier Salvador; Javier A Cienfuegos
Journal:  Obes Surg       Date:  2004-05       Impact factor: 4.129

2.  Gastric bypass operation for obesity.

Authors:  M A Fobi; H Lee; R Holness; D Cabinda
Journal:  World J Surg       Date:  1998-09       Impact factor: 3.352

3.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

4.  Gastroplasty with distal gastric bypass: a new and more successful weight loss operation for the morbidly obese.

Authors:  P A Salmon
Journal:  Can J Surg       Date:  1988-03       Impact factor: 2.089

5.  Growth hormone secretagogue binding sites in peripheral human tissues.

Authors:  M Papotti; C Ghè; P Cassoni; F Catapano; R Deghenghi; E Ghigo; G Muccioli
Journal:  J Clin Endocrinol Metab       Date:  2000-10       Impact factor: 5.958

6.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

7.  Biliopancreatic diversion.

Authors:  N Scopinaro; G F Adami; G M Marinari; E Gianetta; E Traverso; D Friedman; G Camerini; G Baschieri; A Simonelli
Journal:  World J Surg       Date:  1998-09       Impact factor: 3.352

8.  Ghrelin, leptin and insulin levels after restrictive surgery: a 2-year follow-up study.

Authors:  Jeroen Nijhuis; Francois M H van Dielen; Wim A Buurman; Jan Willem M Greve
Journal:  Obes Surg       Date:  2004 Jun-Jul       Impact factor: 4.129

Review 9.  Minireview: adiposity, inflammation, and atherogenesis.

Authors:  Christopher J Lyon; Ronald E Law; Willa A Hsueh
Journal:  Endocrinology       Date:  2003-06       Impact factor: 4.736

Review 10.  Ghrelin: integrative neuroendocrine peptide in health and disease.

Authors:  James T Wu; John G Kral
Journal:  Ann Surg       Date:  2004-04       Impact factor: 12.969

View more
  9 in total

1.  No Effect on Change in Fasting Ghrelin at ≤ 12 Months and Increased at ≥ 24 Months After Roux-en-Y Gastric Bypass.

Authors:  Yong Wang; Jing Chen; Xiao-Ting Wu
Journal:  Obes Surg       Date:  2020-01       Impact factor: 4.129

Review 2.  Effect of Bariatric Surgery on Serum Inflammatory Factors of Obese Patients: a Systematic Review and Meta-Analysis.

Authors:  Moein Askarpour; Dana Khani; Ali Sheikhi; Ehsan Ghaedi; Shahab Alizadeh
Journal:  Obes Surg       Date:  2019-08       Impact factor: 4.129

Review 3.  Mechanisms responsible for excess weight loss after bariatric surgery.

Authors:  Viorica Ionut; Richard N Bergman
Journal:  J Diabetes Sci Technol       Date:  2011-09-01

4.  Hypogonadotropic hypogonadism in morbidly obese males is reversed after bariatric surgery.

Authors:  Silvia Pellitero; Izaskun Olaizola; Antoni Alastrue; Eva Martínez; María Luisa Granada; Jose María Balibrea; Pau Moreno; Assumpta Serra; Maruja Navarro-Díaz; Ramon Romero; Manel Puig-Domingo
Journal:  Obes Surg       Date:  2012-12       Impact factor: 4.129

5.  Inflammatory markers and bariatric surgery: a meta-analysis.

Authors:  S Raghavendra Rao
Journal:  Inflamm Res       Date:  2012-05-16       Impact factor: 4.575

Review 6.  Gastrointestinal hormones and bariatric surgery-induced weight loss.

Authors:  Viorica Ionut; Miguel Burch; Adrienne Youdim; Richard N Bergman
Journal:  Obesity (Silver Spring)       Date:  2013-06       Impact factor: 5.002

7.  Evaluation of Weight Loss Failure, Medical Outcomes, and Personal Experiences after Roux-en-Y Gastric Bypass: A Critical Analysis.

Authors:  Rogier Hörchner; Dave Schweitzer
Journal:  ISRN Obes       Date:  2013-02-14

8.  Consequences of morbid obesity on the kidney. Where are we going?

Authors:  Maruja Navarro Díaz
Journal:  Clin Kidney J       Date:  2016-09-20

Review 9.  Impact of Bariatric Surgery on Adipose Tissue Biology.

Authors:  Óscar Osorio-Conles; Josep Vidal; Ana de Hollanda
Journal:  J Clin Med       Date:  2021-11-25       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.